373 related articles for article (PubMed ID: 8963349)
1. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
Goto T; Onuma T; Takebe K; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
[TBL] [Abstract][Full Text] [Related]
2. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
3. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
4. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
[TBL] [Abstract][Full Text] [Related]
5. Metabolic correlates of eating behavior in severe obesity.
Kral JG; Buckley MC; Kissileff HR; Schaffner F
Int J Obes Relat Metab Disord; 2001 Feb; 25(2):258-64. PubMed ID: 11410829
[TBL] [Abstract][Full Text] [Related]
6. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and body fat distribution in obese subjects.
Basdevant A; Cassuto D; Gibault T; Raison J; Guy-Grand B
Int J Obes Relat Metab Disord; 1994 Dec; 18(12):806-11. PubMed ID: 7894519
[TBL] [Abstract][Full Text] [Related]
8. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins.
Pietiläinen KH; Rissanen A; Kaprio J; Mäkimattila S; Häkkinen AM; Westerbacka J; Sutinen J; Vehkavaara S; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E768-74. PubMed ID: 15585588
[TBL] [Abstract][Full Text] [Related]
9. Slower activation of insulin action in upper body obesity.
Biolo G; Toigo G; Guarnieri G
Metabolism; 2001 Jan; 50(1):19-23. PubMed ID: 11172469
[TBL] [Abstract][Full Text] [Related]
10. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
Johanson EH; Jansson PA; Lönn L; Matsuzawa Y; Funahashi T; Taskinen MR; Smith U; Axelsen M
J Clin Endocrinol Metab; 2003 Sep; 88(9):4232-8. PubMed ID: 12970292
[TBL] [Abstract][Full Text] [Related]
11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
12. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, body mass index and hepatic steatosis are independently associated with IGF-I status in obese non-diabetic women.
Sirbu A; Gologan S; Arbanas T; Copaescu C; Martin S; Albu A; Barbu C; Pirvulescu I; Fica S
Growth Horm IGF Res; 2013; 23(1-2):2-7. PubMed ID: 23111188
[TBL] [Abstract][Full Text] [Related]
14. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
[TBL] [Abstract][Full Text] [Related]
15. Relationships between biochemical abnormalities and anthropometric indices of overweight, adiposity and body fat distribution in Japanese elementary school children.
Asayama K; Hayashibe H; Dobashi K; Uchida N; Kawada Y; Nakazawa S
Int J Obes Relat Metab Disord; 1995 Apr; 19(4):253-9. PubMed ID: 7627249
[TBL] [Abstract][Full Text] [Related]
16. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
17. Effect of liver fat on insulin clearance.
Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of metabolically benign obesity in humans.
Stefan N; Kantartzis K; Machann J; Schick F; Thamer C; Rittig K; Balletshofer B; Machicao F; Fritsche A; Häring HU
Arch Intern Med; 2008 Aug; 168(15):1609-16. PubMed ID: 18695074
[TBL] [Abstract][Full Text] [Related]
19. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
[TBL] [Abstract][Full Text] [Related]
20. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
